Functional roles of gangliosides in neurodevelopment: an overview of recent advances
RK Yu, YT Tsai, T Ariga - Neurochemical research, 2012 - Springer
Gangliosides are sialic acid-containing glycosphingolipids that are most abundant in the
nervous system. They are localized primarily in the outer leaflets of plasma membranes and …
nervous system. They are localized primarily in the outer leaflets of plasma membranes and …
Alzheimer's disease: mechanism and approach to cell therapy
T Amemori, P Jendelova, J Ruzicka… - International journal of …, 2015 - mdpi.com
Alzheimer's disease (AD) is the most common form of dementia. The risk of AD increases
with age. Although two of the main pathological features of AD, amyloid plaques and …
with age. Although two of the main pathological features of AD, amyloid plaques and …
Sialometabolism in brain health and Alzheimer's disease
P Rawal, L Zhao - Frontiers in Neuroscience, 2021 - frontiersin.org
Sialic acids refer to a unique family of acidic sugars with a 9-carbon backbone that are
mostly found as terminal residues in glycan structures of glycoconjugates including both …
mostly found as terminal residues in glycan structures of glycoconjugates including both …
[HTML][HTML] Aβ–ganglioside interactions in the pathogenesis of Alzheimer's disease
K Matsuzaki - Biochimica et Biophysica Acta (BBA)-Biomembranes, 2020 - Elsevier
It is widely accepted that the abnormal self-association of amyloid β-protein (Aβ) is central to
the pathogenesis of Alzheimer's disease, the most common form of dementia. Accumulating …
the pathogenesis of Alzheimer's disease, the most common form of dementia. Accumulating …
Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: prevention by correcting lysosomal proteolytic deficits
DS Yang, P Stavrides, M Saito, A Kumar… - Brain, 2014 - academic.oup.com
Autophagy, the major lysosomal pathway for the turnover of intracellular organelles is
markedly impaired in neurons in Alzheimer's disease and Alzheimer mouse models. We …
markedly impaired in neurons in Alzheimer's disease and Alzheimer mouse models. We …
Delineating amyloid plaque associated neuronal sphingolipids in transgenic Alzheimer's disease mice (tgArcSwe) using MALDI imaging mass spectrometry
The major pathological hallmarks of Alzheimer's disease (AD) are the progressive
aggregation and accumulation of beta-amyloid (Aβ) and hyperphosphorylated tau protein …
aggregation and accumulation of beta-amyloid (Aβ) and hyperphosphorylated tau protein …
Sphingolipid players in multiple sclerosis: their influence on the initiation and course of the disease
M Podbielska, T Ariga, A Pokryszko-Dragan - International journal of …, 2022 - mdpi.com
Sphingolipids (SLs) play a significant role in the nervous system, as major components of
the myelin sheath, contributors to lipid raft formation that organize intracellular processes, as …
the myelin sheath, contributors to lipid raft formation that organize intracellular processes, as …
Cholesterol accelerates the binding of Alzheimer's β-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid …
Age-related alterations of membrane lipids in brain cell membranes together with high blood
cholesterol are considered as major risk factors for Alzheimer's disease. Yet the molecular …
cholesterol are considered as major risk factors for Alzheimer's disease. Yet the molecular …
Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker …
Background Understanding of the significance of posttranslational glycosylation in
Alzheimer's disease (AD) is of growing importance for the investigation of the pathogenesis …
Alzheimer's disease (AD) is of growing importance for the investigation of the pathogenesis …
Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity
Abstract Background Alzheimer's Disease (AD) affects millions globally, but therapy
development is lagging. New experimental systems that monitor neuronal functions in …
development is lagging. New experimental systems that monitor neuronal functions in …